30.12.2016 18:22:59
|
Mylan Posting Strong Gain After Launching Generic Concerta, Cerebyx
(RTTNews) - Mylan (MYL) is posting a strong gain in afternoon trading on Friday, with shares of the drug maker climbing by 2.5 percent. Earlier in the session, Mylan reached its best intraday level in well over a month.
The gain by Mylan comes after the company announced the launch of a generic version on Johnson & Johnson's (JNJ) Concerta tablets for the treatment of Attention Deficit Hyperactivity Disorder.
Mylan also announced the launch of a generic version of Pfizer's (PFE) Cerebyx injection for the treatment of certain types of severe seizures.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Mylan Incmehr Nachrichten
Keine Nachrichten verfügbar. |